Cardiac Evaluation in Liver Transplantation
- 5 Downloads
Purpose of Review
With more than 14,000 patients awaiting liver transplantation in the USA and a mortality rate of 20–25% on the wait list, a diligent pre-operative evaluation is crucial to ensure optimal risk assessment. Cardiac disease remains the leading cause of early mortality after liver transplantation. In this review, we discuss common cardiac comorbidities, frequently used testing modalities, and updated literature on cardiac evaluation in liver transplant candidates.
Optimal cardiac evaluation, especially in the asymptomatic patient, remains controversial as shown by conflicting results in the literature. Non-invasive testing is associated with low sensitivity in this patient population; therefore, coronary angiography remains the standard for detecting CAD.
There is general agreement that all liver transplant candidates have to undergo cardiac evaluation; however, universally accepted guidelines are currently not available. Often the choice of the cardiac evaluation modality has to be made on a case-by-case basis by a multidisciplinary transplant team based on the perceived risk of invasive studies when compared to perioperative cardiac events.
KeywordsLiver transplantation Pre-operative cardiac evaluation Cirrhotic cardiomyopathy Perioperative mortality Post-operative complications
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Humar A, Ganesh S, Jorgensen D, Tevar A, Ganoza A, Molinari M, et al. Adult living donor versus deceased donor liver transplant (LDLT versus DDLT) at a single center: time to change our paradigm for liver transplant. Ann Surg. 2019;1.Google Scholar
- 10.Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996;61:1180–8.PubMedCrossRefPubMedCentralGoogle Scholar
- 12.• Patel SS, Nabi E, Guzman L, et al. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transpl. 2018;24:333–42 This study identifies NASH and HCV as independent risk factors for CAD in liver transplant candidates.PubMedCrossRefPubMedCentralGoogle Scholar
- 23.Balogh J, Lunsford K, Nguyen D, Gravis E, Cercio O, Mobley C, Saharia A, Burroughs SG, Gaber A, Ghobrial R. Risk analysis of patients with proven coronary artery disease undergoing liver transplant.Google Scholar
- 30.VanWagner LB, Harinstein ME, Runo JR, Darling C, Serper M, Hall S, et al. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations. Am J Transplant. 2017;18:30–42.PubMedPubMedCentralCrossRefGoogle Scholar
- 41.Wilkey BJ, Hanson R, Reece TB, et al. Transfemoral transcatheter aortic valve replacement for mixed aortic valve disease in child’s class C liver disease prior to orthotopic liver transplantation: a case report. Semin Cardiothorac Vasc Anesth. 2016;20:158–62.PubMedCrossRefPubMedCentralGoogle Scholar
- 59.Senzolo M, Bassanello M, Graziotto A, Zucchetta P, Cillo U, Maraglino G, et al. Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation. Transplant Proc. 2008;40:1916–7.PubMedCrossRefPubMedCentralGoogle Scholar
- 63.Duvall WL, Singhvi A, Tripathi N, Henzlova MJ. SPECT myocardial perfusion imaging in liver transplantation candidates. J Nucl Cardiol. 2018;13:280.Google Scholar
- 65.Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008;1:202–9.PubMedCrossRefPubMedCentralGoogle Scholar
- 70.• Bernal W, Martin-Mateos R, Lipcsey M, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54–62 This study has shown that impaired aerobic capacity was closely related to the duration of post-transplant hospitalization.PubMedCrossRefPubMedCentralGoogle Scholar
- 76.Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278–333.PubMedPubMedCentralGoogle Scholar